Robert Kang

Part of Albert Labs International Corp., Albert Labs, Inc. is a pharmaceutical company based in London, UK. The private company provides Psychedelic Therapy for UK & Europe, accelerating access for those suffering most in society with mental health. Albert Labs is focused on natural drug development, delivering faster access to novel mental health therapies for unmet needs. The British company is committed to ensuring transparency in their business and supply chains, and will not tolerate modern slavery. The CEO of the company is Michael Raymont. Albert Labs was acquired by ME Resource Corp. on March 10, 2022 for $0.16 million.

Part of Albert Labs International Corp., Albert Labs, Inc. is a pharmaceutical company based in London, UK. The private company provides Psychedelic Therapy for UK & Europe, accelerating access for those suffering most in society with mental health. Albert Labs is focused on natural drug development, delivering faster access to novel mental health therapies for unmet needs. The British company is committed to ensuring transparency in their business and supply chains, and will not tolerate modern slavery. The CEO of the company is Michael Raymont. Albert Labs was acquired by ME Resource Corp. on March 10, 2022 for $0.16 million.

Part of Albert Labs International Corp., Albert Labs, Inc. is a pharmaceutical company based in London, UK. The private company provides Psychedelic Therapy for UK & Europe, accelerating access for those suffering most in society with mental health. Albert Labs is focused on natural drug development, delivering faster access to novel mental health therapies for unmet needs. The British company is committed to ensuring transparency in their business and supply chains, and will not tolerate modern slavery. The CEO of the company is Michael Raymont. Albert Labs was acquired by ME Resource Corp. on March 10, 2022 for $0.16 million.